Cutaneous small vessel vasculitis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Cutaneous small vessel vasculitis.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Cutaneous small vessel vasculitis.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

IMPAVIDO

(miltefosine)Orphan drugstandard

Knight Therapeutics (USA)

Antileishmanial [EPC]

12.1 Mechanism of Action Miltefosine is an anti-leishmanial agent [see Clinical Pharmacology ( 12.4 )] .

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Cutaneous small vessel vasculitis.
Search all trials →
Search clinical trials for Cutaneous small vessel vasculitis

Recent News & Research

No recent news articles indexed yet for Cutaneous small vessel vasculitis.
Search PubMed for Cutaneous small vessel vasculitis

Browse all Cutaneous small vessel vasculitis news →

Specialist Network

Top 4 by expertise

View all Cutaneous small vessel vasculitis specialists →

Quick Actions